Abstract

The beneficial effects of platelet glycoprotein IIb/IIIa inhibition with abciximab during primary angioplasty for acute MI are well known. However, the

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call